Delta Medical Kazakhstan

Kazakhstan is facing a dilemma in ensuring access to medicines for patients with rare diseases while managing budget constraints.  The country officially recognizes 66 groups of orphan diseases, with over 80,000 registered patients, including 21,000 children.  Current Orphan Medicine Financing and Access in Kazakhstan Currently, Kazakhstan reimburses 42 orphan medicines at the national level out

Kazakhstan is implementing major healthcare reforms to empower nurses and expand their roles, aiming to enhance patient care quality and efficiency. The Ministry of Health is developing new regulations that will allow nurses to assume more responsibilities and work with greater autonomy. Nurses to Conduct Independent Patient Appointments Under the new regulations, nurses will have

President Kassym-Jomart Tokayev has signed into law the “On Amendments and Additions to Certain Legislative Acts of the Republic of Kazakhstan on Healthcare”.  This new legislation aims to enhance the legal and financial protection of medical workers, increase their responsibility, and combat the spread of nicotine-containing substances among youth. Professional Liability Insurance for Kazakh Medical

Delta Medical, a leading Swiss pharmaceutical company, proudly sponsored the “IRON ACADEMY” project – a series of educational lectures and roundtable discussions focused on the critical issue of iron deficiency anemia (IDA) in Kazakhstan.  The events, held in various cities including Astana, Almaty, and Kyzylorda, brought together over 350 healthcare professionals including obstetrician-gynecologists, hematologists, and